AL-3152 - CAS 126048-33-7
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
AL-3152
Catalog Number:
126048-33-7
Synonyms:
2,7-difluoro-4-methoxy-Spiro(9H-fluorene-9,4'-imidazolidine)-2',5'-dione
CAS Number:
126048-33-7
Description:
AL-3152 is a aldehyde reductase inhibitors originated by Alcon. But clinical trials was discontinued for the treatment of Diabetic nephropathies, Diabetic neuropathies and Diabetic retinopathy.
Molecular Weight:
316.62
Molecular Formula:
C16H10F2N2O3
Quantity:
Milligrams-Grams
Quality Standard:
In-house standard
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
N1[C@@]2(c3cc(ccc3c3c(cc(cc23)F)OC)F)C(=O)NC1=O
InChI:
1S/C16H10F2N2O3/c1-23-12-6-8(18)5-11-13(12)9-3-2-7(17)4-10(9)16(11)14(21)19-15(22)20-16/h2-6H,1H3,(H2,19,20,21,22)
InChIKey:
FYDPXVSFSSBHGW-UHFFFAOYSA-N
Targets:
Aldehyde Reductase
Current Developer:
Originator:Alcon

Related Aldehyde Reductase Products


AL-3152
(CAS: 126048-33-7)

AL-3152 is a aldehyde reductase inhibitors originated by Alcon. But clinical trials was discontinued for the treatment of Diabetic nephropathies, Diabetic neuro...

CAS 136087-85-9 Fidarestat

Fidarestat
(CAS: 136087-85-9)

Fidarestat is a aldose reductase inhibitor originated by Sanwa Kagaku Kenkyusho. It was very effective in significantly alleviating some symptoms of diabetic po...

CAS 129688-50-2 Minalrestat

Minalrestat
(CAS: 129688-50-2)

Minalrestat is an aldose reductase inhibitor originated by Wyeth. In Aug 2002, Phase-III for Diabetic retinopathy was discontinued in USA and Europe.